METABOLIX, INC. 6,200,000 Shares of Common Stock Underwriting AgreementMetabolix, Inc. • May 19th, 2011 • Miscellaneous plastics products • New York
Metabolix, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC is acting as the sole representative (the “Representative”), an aggregate of 6,200,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 930,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares include 2,278,500 shares of common stock, par value $0.01 per share, of the company (the “Other Underwritten Shares”) to be purchased by an existing stockholder of the Company who is an affiliate of a director of the Company and certain other directors and officers of the Company (the “Other Underwritten Share Purchasers”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstand
